JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2024 • Armen Garo H • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of them of a statement on Schedule 13D (including amendments thereto) with respect to the common stock, par value $.00001 per share, of MiNK Therapeutics, Inc., and further agree that this Joint Filing Agreement be included as Exhibit 99.1.
